Literature DB >> 9662252

Thymidylate synthase expression and activity: relation to S-phase parameters and 5-fluorouracil sensitivity.

J F Mirjolet1, M Barberi-Heyob, J L Merlin, S Marchal, M C Etienne, G Milano, P Bey.   

Abstract

Six human cancer cell lines exhibiting a large range of sensitivity to 5-fluorouracil (5-FU) were evaluated for thymidylate synthase (TS) and p53 gene expression, TS and dihydropyrimidine dehydrogenase (DPD) activity, as well as cell cycle parameters, S-phase fraction (SPF), bromodeoxyuridine labelling index (LI) and S-phase duration (SPD). All these parameters were investigated for 7 days in asynchronously growing cell populations and compared with the cell sensitivity to 5-FU. No significant correlation was found between S-phase parameters and TS gene expression and/or activity. TS activity was higher in proliferating cells; however, it was not significantly higher in rapidly growing cell lines with short SPD. Neither TS gene expression nor activity was found to correlate with 5-FU sensitivity. On the another hand, a statistically significant correlation (P < 0.0001) was observed between LI and SPD and 5-FU sensitivity. The present results suggest that cell cycle parameters such as SPD and/or LI could be better parameters for 5-FU sensitivity prediction than TS gene expression and/or activity. This could be especially informative in cases of concomitant radio-chemotherapy as S-phase parameters are already proposed for hyperfractionated radiotherapy planning.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9662252      PMCID: PMC2062951          DOI: 10.1038/bjc.1998.443

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  24 in total

1.  Thymidylate synthetase activity in cultured mammalian cells.

Authors:  A H Conrad
Journal:  J Biol Chem       Date:  1971-03-10       Impact factor: 5.157

2.  Assessment of growth-limiting events caused by 5-fluorouracil in mouse cells and in human cells.

Authors:  R M Evans; J D Laskin; M T Hakala
Journal:  Cancer Res       Date:  1980-11       Impact factor: 12.701

3.  The role of thymidylate synthase in cellular regulation.

Authors:  E Chu; C J Allegra
Journal:  Adv Enzyme Regul       Date:  1996

4.  Induction of thymidylate synthase associated with multidrug resistance in human breast and colon cancer cell lines.

Authors:  E Chu; J C Drake; D M Koeller; S Zinn; C A Jamis-Dow; G C Yeh; C J Allegra
Journal:  Mol Pharmacol       Date:  1991-02       Impact factor: 4.436

5.  Autoregulation of human thymidylate synthase messenger RNA translation by thymidylate synthase.

Authors:  E Chu; D M Koeller; J L Casey; J C Drake; B A Chabner; P C Elwood; S Zinn; C J Allegra
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

6.  A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumour sensitivity to fluorouracil.

Authors:  A Beck; M C Etienne; S Chéradame; J L Fischel; P Formento; N Renée; G Milano
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

7.  Bcl-2, Bax and p53 expression in B-CLL in relation to in vitro survival and clinical progression.

Authors:  M Aguilar-Santelises; M E Rottenberg; N Lewin; H Mellstedt; M Jondal
Journal:  Int J Cancer       Date:  1996-04-22       Impact factor: 7.396

8.  Evaluation of plasma 5-fluorouracil nucleoside levels in patients with metastatic breast cancer: relationships with toxicities.

Authors:  M Barberi-Heyob; B Weber; J L Merlin; C Dittrich; E A de Bruijn; E Luporsi; F Guillemin
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

9.  Lack of correlation between thymidylate synthase levels in primary colorectal tumours and subsequent response to chemotherapy.

Authors:  M P Findlay; D Cunningham; G Morgan; S Clinton; A Hardcastle; G W Aherne
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

10.  Increased thymidylate synthase protein levels are principally associated with proliferation but not cell cycle phase in asynchronous human cancer cells.

Authors:  B C Pestalozzi; C J McGinn; T J Kinsella; J C Drake; M C Glennon; C J Allegra; P G Johnston
Journal:  Br J Cancer       Date:  1995-06       Impact factor: 7.640

View more
  10 in total

Review 1.  [18F]FLT-PET in oncology: current status and opportunities.

Authors:  Lukas B Been; Albert J H Suurmeijer; David C P Cobben; Pieter L Jager; Harald J Hoekstra; Philip H Elsinga
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-12       Impact factor: 9.236

2.  Mechanism of 5-fluorouracil required resistance in human hepatocellular carcinoma cell line Bel(7402).

Authors:  Jing Jin; Min Huang; Huai-Ling Wei; Geng-Tao Liu
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

3.  Circadian expression of clock genes in human oral mucosa and skin: association with specific cell-cycle phases.

Authors:  G A Bjarnason; R C Jordan; P A Wood; Q Li; D W Lincoln; R B Sothern; W J Hrushesky; Y Ben-David
Journal:  Am J Pathol       Date:  2001-05       Impact factor: 4.307

4.  Tumor growth rate determines the timing of optimal chronomodulated treatment schedules.

Authors:  Samuel Bernard; Branka Cajavec Bernard; Francis Lévi; Hanspeter Herzel
Journal:  PLoS Comput Biol       Date:  2010-03-19       Impact factor: 4.475

5.  Thymidylate synthase protein expression and activity are related to the cell proliferation rate in human cancer cell lines.

Authors:  M Derenzini; L Montanaro; D Treré; A Chillà; P L Tazzari; F Dall'Olio; D Ofner
Journal:  Mol Pathol       Date:  2002-10

6.  Antisense targeting of thymidylate synthase (TS) mRNA increases TS gene transcription and TS protein: effects on human tumor cell sensitivity to TS enzyme-inhibiting drugs.

Authors:  Tracey L H Jason; Randal W Berg; Mark D Vincent; James Koropatnick
Journal:  Gene Expr       Date:  2007

Review 7.  MiRNAs and LincRNAs: Could they be considered as biomarkers in colorectal cancer?

Authors:  Ruth Zarate; Valentina Boni; Eva Bandres; Jesús Garcia-Foncillas
Journal:  Int J Mol Sci       Date:  2012-01-16       Impact factor: 6.208

8.  Docetaxel-titanate nanotubes enhance radiosensitivity in an androgen-independent prostate cancer model.

Authors:  Céline Mirjolet; Julien Boudon; Alexis Loiseau; Sandy Chevrier; Romain Boidot; Alexandra Oudot; Bertrand Collin; Etienne Martin; Pattayil Alias Joy; Nadine Millot; Gilles Créhange
Journal:  Int J Nanomedicine       Date:  2017-08-30

9.  Quantitative measurement of thymidylate synthase and dihydropyrimidine dehydrogenase mRNA level in gastric cancer by real-time RT-PCR.

Authors:  Hisataka Fujiwara; Masanori Terashima; Takashi Irinoda; Akinori Takagane; Kaoru Abe; Masahiro Kashiwaba; Kennichi Oyama; Masanori Takahashi; Chihaya Maesawa; Kazuyoshi Saito; Teiji Takechi; Masakazu Fukushima
Journal:  Jpn J Cancer Res       Date:  2002-12

Review 10.  The use of molecular imaging combined with genomic techniques to understand the heterogeneity in cancer metastasis.

Authors:  R Chowdhury; B Ganeshan; S Irshad; K Lawler; M Eisenblätter; H Milewicz; M Rodriguez-Justo; K Miles; P Ellis; A Groves; S Punwani; T Ng
Journal:  Br J Radiol       Date:  2014-03-06       Impact factor: 3.039

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.